Barclays maintains Hain Celestial Group at Underweight, lowers price target to $0.10 from $0.30

Barclays kept its Underweight rating on Hain Celestial Group but reduced its price target to $0.10 from $0.30, a 66.7% cut. This suggests a 28.4% downside from the Nov 9 close of $0.14, according to the bank.

Original reporting
Published Nov 10, 2026, 2:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 2:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Barclays maintains Hain Celestial Group at Underweight, lowers price target to $0.10 from $0.30 — source image
Decision brief

The 30-second read

$HAINBearishLow
01

Why it matters

The downgrade reduces the stock's upside potential and may trigger short‑term selling.

02

Market read

Analyst target cuts are a common catalyst for price moves in small‑cap stocks.

03

What to watch

Potential upcoming product launches or cost reductions not reflected in the downgrade.

Relevance 5/10Novelty 5/10Timing: today

Background

Barclays' research note updates its valuation for Hain Celestial Group, a small‑cap consumer‑goods company.

Company-level read

Ticker impact

$HAINBearishMedium confidence
Context

Barclays cut Hain Celestial Group's price target to $0.10 from $0.30, implying a 66.7% downgrade.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

Target cut signals reduced valuation expectations, which typically leads to sell pressure.

Counterpoint

The target cut may be overly pessimistic if the company can improve margins.

Key entities

  • Barclays

    Equity research firm issuing the price target cut.

  • Hain Celestial Group

    US‑listed consumer products company (ticker HAIN).

Related articles

$HAINMedAI 8/10

Hain Celestial (HAIN) Q1 2027 Earnings Call Transcript

Hain Celestial (HAIN) reported Q1 2027 net sales of $260M, down 29.3% YoY due to divestitures. Adjusted gross margin rose to 22.8%, while net loss narrowed to $11M. International business sale to Aurelius awaits credit agreement amendment. Management plans $16M in annual cost savings and increased marketing investment.

$HAINMedAI 8/10

Hain Celestial's Clears Regulatory Hurdle For International Unit Sale

Hain Celestial (HAIN) received final regulatory approvals for selling its International business to Aurelius, though a credit agreement condition was not met. The company reported a 29% decline in Q1 net sales to $260M, with a 7% organic sales drop. Gross profit margin rose 330 basis points to 21.8%, and net loss narrowed to $11M. The North America unit saw a 6% sales decline, while the International unit had a 7% sales decrease.